1. Home
  2. MDRR vs IRIX Comparison

MDRR vs IRIX Comparison

Compare MDRR & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MDRR

Medalist Diversified REIT Inc.

HOLD

Current Price

$11.52

Market Cap

18.3M

Sector

Real Estate

ML Signal

HOLD

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

HOLD

Current Price

$1.16

Market Cap

18.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDRR
IRIX
Founded
2015
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.3M
18.2M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
MDRR
IRIX
Price
$11.52
$1.16
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.9K
44.4K
Earning Date
03-02-2026
05-12-2026
Dividend Yield
2.43%
N/A
EPS Growth
N/A
51.85
EPS
N/A
N/A
Revenue
N/A
$41,593,000.00
Revenue This Year
N/A
$3.07
Revenue Next Year
N/A
$6.66
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.47
$0.87
52 Week High
$14.52
$1.65

Technical Indicators

Market Signals
Indicator
MDRR
IRIX
Relative Strength Index (RSI) 52.43 49.75
Support Level $11.48 $1.01
Resistance Level $12.20 $1.18
Average True Range (ATR) 0.32 0.04
MACD 0.02 -0.01
Stochastic Oscillator 46.77 22.22

Price Performance

Historical Comparison
MDRR
IRIX

About MDRR Medalist Diversified REIT Inc.

Medalist Diversified Inc owns ten investment properties comprised of three retail properties, three flex/industrial properties, and four STNL properties, including the Tesla Pensacola Property. Through its subsidiary, the company sponsors Delaware Statutory Trusts (DSTs) that provide accredited investors access to institutional-quality real estate with the transparency and governance of a public company. The company has three reportable segments, consisting of retail center properties, flex center properties, and STNL properties. The company generates the majority of its revenue from the Retail Center Property.

About IRIX IRIDEX Corporation

IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Share on Social Networks: